NLA Recommendations for Patient-Centered
Management of Dyslipidemia

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report

Terry A. Jacobson, MD, Matthew K. Ito, PharmD, Kevin C. Maki, PhD, Carl E. Orringer, MD, Harold E. Bays, MD, Peter H. Jones, MD, James M. McKenney, PharmD, Scott M. Grundy, MD, PhD, Edward A. Gill, MD, Robert A. Wild, MD, PhD, Don P. Wilson, MD, W. Virgil Brown, MD

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

Terry A. Jacobson, MD, Kevin C. Maki, PhD, Carl E. Orringer, MD, Peter H. Jones, MD, Penny Kris-Etherton, PhD, Geeta Sikand, MA, Ralph La Forge, MSc, Stephen R. Daniels, MD, PhD, Don P. Wilson, MD, Pamela B. Morris, MD, Robert A. Wild, MD, PhD, MPH, Scott M. Grundy, MD, PhD, Martha Daviglus, MD, PhD, Keith C. Ferdinand, MD, Krishnaswami Vijayaraghavan, MD, Prakash C. Deedwania, MD, Judith A. Aberg, MD, Katherine P. Liao, MD, MPH, James M. McKenney, PharmD, Joyce L. Ross, MSN, CRNP, Lynne T. Braun, PhD, CNP, Matthew K. Ito, PharmD, Harold E. Bays, MD, W. Virgil Brown, MD On behalf of the NLA Expert Panel

National Lipid Association Updated Recommendations on the Use of PCSK9 Inhibitors

Carl E. Orringer, MD, Terry A. Jacobson, MD, Joseph J. Saseen, PharmD, Alan S. Brown, MD, Antonio M. Gotto, MD, Joyce L. Ross MSN, CRNP, James A. Underberg, MD